Pterostilbene exerts anti-lung squamous cell carcinoma function by suppressing the level of KANK3
View abstract on PubMed
Summary
This summary is machine-generated.Pterostilbene (PT) combats lung squamous cell carcinoma (LUSC) by inhibiting KANK3. This natural compound
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- Early detection of lung squamous cell carcinoma (LUSC) is crucial for improving patient outcomes.
- Pterostilbene (PT), a natural compound, exhibits potential anti-cancer properties.
- Identifying reliable biomarkers and understanding therapeutic mechanisms are key challenges in LUSC treatment.
Purpose Of The Study
- To identify novel biomarkers for LUSC through bioinformatic analysis and clinical validation.
- To investigate the role of KANK3 as a potential LUSC biomarker.
- To explore the therapeutic interaction between pterostilbene (PT) and KANK3 in LUSC treatment.
Main Methods
- Differential gene expression analysis of LUSC clinical samples to identify differentially expressed genes (DEGs).
- Immunohistochemistry (IHC) for clinical validation of identified biomarkers.
- In vitro and in vivo assays to assess the role of KANK3 in PT's anti-LUSC effects.
- Functional assays including cell viability, apoptosis, migration, and invasion assays.
Main Results
- Identification of 4335 DEGs in LUSC, with 1851 upregulated and 2484 downregulated genes.
- KANK3 expression was significantly elevated in advanced-stage LUSC patients.
- Pterostilbene (PT) treatment reduced LUSC cell viability, induced apoptosis, and inhibited migration/invasion, correlating with KANK3 downregulation.
- Re-expression of KANK3 in LUSC cells diminished the anti-tumor effects of PT.
- In a mouse model, KANK3 reinduction promoted tumor growth and metastasis despite PT treatment.
Conclusions
- KANK3 is a potential biomarker for advanced LUSC and plays a critical role in tumor progression.
- Pterostilbene (PT) exerts its anti-LUSC effects by inhibiting KANK3 expression and function.
- Targeting KANK3 could be a promising therapeutic strategy for LUSC, potentially enhancing PT efficacy.
Related Concept Videos
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

